002437.SZ
誉衡药业
SZSE · Healthcare · C 制造业 · CN
CNY 3.94
−9.43%Margins
Gross margin
44.5%
EBITDA margin
23.3%
EBIT margin
20.9%
Net margin
19.4%
FCF margin
10.3%
17.2%
Return on equity
13.1%
Return on assets
18.4%
Return on invested capital
0.68x
Asset turnover
CNY 239.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026